Versant Venture Capital VI, L.P., 10% Owner at LENZ Therapeutics, Inc. (LENZ), sold 209,153 shares at $41.59 ($8.8M) on 2025-09-18, disclosed to the SEC on 2025-09-22.
Open-market sale of $8.8M LENZ by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.59 | 49,479 | $2.1M | 23.4% |
| 2 | $41.59 | 24,370 | $1.0M | 11.5% |
| 3 | $41.59 | 24,370 | $1.0M | 11.5% |
| 4 | $41.59 | 49,479 | $2.1M | 23.4% |
| 5 | $43.00 | 20,148 | $866K | 9.9% |
| 6 | $43.00 | 40,907 |
| $1.8M |
| 20.0% |
| 7 | $43.30 | 132 | $6K | 0.1% |
| 8 | $43.30 | 268 | $12K | 0.1% |
| Total | $42.00 avg | 209,153 | $8.8M | 100% |
| Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |
| OYST | SELL | 2021-10-20 | $16.3M | — | Filing → |